Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the <i>Helicobacter pylori</i> Genome Project
Prophages can have major clinical implications through their ability to change pathogenic bacterial traits. There is limited understanding of the prophage role in ecological, evolutionary, adaptive processes and pathogenicity of <i>Helicobacter pylori</i>, a widespread bacterium causally associated with gastric cancer. Inferring the exact prophage genomic location and completeness requires complete genomes. The international <i>Helicobacter pylori</i> Genome Project (<i>Hp</i>GP) dataset comprises 1011 <i>H. pylori</i> complete clinical genomes enriched with epigenetic data. We thoroughly evaluated the <i>H. pylori</i> prophage genomic content in the <i>Hp</i>GP dataset. We investigated population evolutionary dynamics through phylogenetic and pangenome analyses. Additionally, we identified genome rearrangements and assessed the impact of prophage presence on bacterial gene disruption and methylome. We found that 29.5% (298) of the <i>Hp</i>GP genomes contain prophages, of which only 32.2% (96) were complete, minimizing the burden of prophage carriage. The prevalence of <i>H. pylori</i> prophage sequences was variable by geography and ancestry, but not by disease status of the human host. Prophage insertion occasionally results in gene disruption that can change the global bacterial epigenome. Gene function prediction allowed the development of the first model for lysogenic-lytic cycle regulation in <i>H. pylori</i>. We have disclosed new prophage inactivation mechanisms that appear to occur by genome rearrangement, merger with other mobile elements, and pseudogene accumulation. Our analysis provides a comprehensive framework for <i>H. pylori</i> prophage biological and genomics, offering insights into lysogeny regulation and bacterial adaptation to prophages.
Authors
- Filipa F. Vale (ORCID: https://orcid.org/0000-0003-4635-0105)
- Charles S. Rabkin (ORCID: https://orcid.org/0000-0002-0053-3806)
- M. Constanza Camargo (ORCID: https://orcid.org/0000-0002-1065-2198)
- Ichizo Kobayashi (ORCID: https://orcid.org/0000-0002-3854-1879)
- Richard J. Roberts (ORCID: https://orcid.org/0000-0002-4348-0169)
Institutions
- New England Biolabs (United States) (US)
- National Institute for Basic Biology (JP)
- University of Lisbon (PT)
- Hosei University (JP)
- National Cancer Institute (US)
- Division of Cancer Epidemiology and Genetics
- The University of Tokyo (JP)
Publication Details
- Journal
- Gut Microbes
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1080/19490976.2024.2379440
- Citations
- 12
- Primary Topic
- Bacteriophages and microbial interactions
- Type
- article
- Field-Weighted Citation Impact
- 5.51
Funders
- Health Research
- National Cancer Center
- ArcticNet
- European Commission
- National Research Foundation
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Bundesministerium für Bildung und Forschung
- Ministry of Higher Education
- Ministry of Education
- Ministero della Salute
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Ministry of Science and Technology
- Universiti Malaya
- Ministry of Health, British Columbia
- Universidad de Costa Rica
- Institut National Du Cancer
- Alberta Innovates
- Agencia Nacional de Investigación y Desarrollo
- National Institutes of Health
- National Medical Research Council
- Fundação para a Ciência e a Tecnologia
- Comisión Nacional de Investigación Científica y Tecnológica
- Horizon 2020
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- U.S. National Library of Medicine
- National Institute on Minority Health and Health Disparities
- Fondo Nacional de Desarrollo Científico y Tecnológico
- Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias